Amgen psoriatic arthritis drug maintains efficacy after 1 yr -study

June 11 (Reuters) - A drug being developed by Amgen Inc for psoriatic arthritis demonstrated sustained effectiveness after a year of treatment with no new safety concerns, according to data from a midstage trial.